Methyl inosine monophosphate: A potential immunotherapeutic for early human immunodeficiency virus (HIV) infection

This publication has 9 references indexed in Scilit:

• Thymic hormone/interteukin-1 (IL-1)/Zn++ complex activate a nuclear pool of protein kinase C (PKC) in rat splenocytes
  International Journal of Immunopharmacology, 1991
• A Phase I Evaluation of the Safety and Immunogenicity of Vaccination with Recombinant gp160 in Patients with Early Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1991
• In vitro immunomodulation and in vivo immunotherapy of retrovirus-induced immunosuppression
  International Journal of Immunopharmacology, 1991
• Inhibition of interleukin-2 production by tumor cell products and by CKS-17, a synthetic retroviral envelope peptide
  Cancer Immunology, Immunotherapy, 1990
• Effects of cytokines on human thymic epithelial cells in culture
  Cellular Immunology, 1990
• The Efficacy of Inosine Pranobex in Preventing the Acquired Immunodeficiency Syndrome in Patients with Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1990
• Inhibition of protein kinase C and anti-CD3-induced Ca2+ influx in Jurkat T cells by a synthetic peptide with sequence identity to HIV-1 gp41.
  The Journal of Immunology, 1990
• Quantitation of Human Immunodeficiency Virus Type 1 in the Blood of Infected Persons
  New England Journal of Medicine, 1989
• Synthetic peptide corresponding to a conserved domain of the retroviral protein p15E blocks IL-1-mediated signal transduction.
  The Journal of Immunology, 1989